IFGL Refractories Q4 Results 2026: Date, Revenue, PAT And Analyst Outlook

IFGL Refractories (NSE: IFGLEXPOR) is set to announce its Q4 FY26 (January–March 2026) results on May 12, 2026. Trading at Rs 680 as of April 2026 — down -35% from its 52-week high of Rs 1,050 — the stock enters this pivotal results event having already corrected meaningfully from peak levels. Q4 FY26 delivers the full-year FY26 performance and the first formal FY27 management guidance.

This preview covers the confirmed results date, analyst consensus estimates, five key performance factors, five risks to monitor, analyst ratings, and the complete share price outlook for IFGL Refractories ahead of Q4 FY26 results.

Get free investment predictions from SEBI-registered analysts on Univest.

IFGL Refractories Q4 Results 2026 Date

The IFGL Refractories Q4 FY26 results date is May 12, 2026. The board will approve Q4 and full-year FY26 financial results, consider a final dividend for FY26, and provide management’s first formal FY27 business outlook.

Why Q4 FY26 Matters

Q4 FY26 is the final quarter of FY2025–26 and carries the highest informational weight of any quarterly result. Beyond the Q4 standalone performance, the IFGL Refractories board on May 12, 2026 will deliver the complete FY26 annual performance, a final dividend recommendation, and the first formal FY27 guidance commentary — making this the single most important quarterly event for IFGL Refractories investors.

For IFGL Refractories in the Refractories / Steel Consumables sector, Q4 captures the peak-season demand dynamics that typically deliver the quarter’s strongest operating leverage when execution conditions are favourable.

IFGL Refractories Q4 FY26 Earnings Estimates

Access premium analyst research on Univest.

Screen IFGL Refractories live on the Univest Screener — real-time fundamentals, FII/DII flows, and analyst ratings.

Download the Univest iOS App or Univest Android App for live Q4 result alerts.

5 Key Factors Driving IFGL Refractories Q4 FY26 Performance

1. India Branded Generic Growth

India pharmaceutical market growing at 8-10% annually. Q4 captures year-end prescription momentum.

2. US Generic Revenue

ANDA approvals and generic launches drive US export revenue. First-to-file paragraphs provide 180-day exclusivity.

3. CDMO Revenue

Contract manufacturing for global innovators provides long-term, high-margin revenue.

4. New Product Launches

New OTC and branded generic launches in India expand domestic market share.

5. API Cost Normalisation

Global API price moderation benefits formulation company gross margins.

5 Risks to Watch in IFGL Refractories Q4 FY26

Risk 1: Input Cost Volatility

Raw material and input cost changes can compress margins unexpectedly.

Risk 2: Revenue Concentration Risk

Customer or geographic concentration creates quarterly variance.

Risk 3: Competitive Pressure

Intensified sector competition may require price or volume concessions.

Risk 4: Regulatory Environment

Policy and regulatory changes can create compliance cost or revenue risks.

Risk 5: Macroeconomic Sensitivity

Global and domestic conditions — tariffs, interest rates, consumption — affect demand.

IFGL Refractories Share Price and Analyst Ratings

Conclusion

IFGL Refractories Q4 FY26 results on May 12, 2026 will be the most important quarterly event of FY26. At Rs 680 — down -35% from its 52-week high of Rs 1,050 — the stock has already priced in significant headwinds. Revenue above Rs 285 Cr with EBITDA 12% would constitute a beat versus analyst consensus. Management’s FY27 guidance is the primary re-rating catalyst that determines whether the current level represents an entry opportunity.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All data sourced from publicly available information. Verify before investing. Consult a SEBI-registered financial advisor before making investment decisions.

For more Q4 FY26 results previews, visit Univest Blogs.

Frequently Asked Questions

Q: When is IFGL Refractories Q4 results 2026 date?

IFGL Refractories Q4 FY26 results date is May 12, 2026. The board will approve the audited Q4 and full-year FY26 financial results, consider a final dividend, and provide FY27 guidance.

Q: What is IFGL Refractories Q4 FY26 revenue estimate?

Analyst consensus Q4 FY26 revenue estimate for IFGL Refractories is Rs 285 Cr. Q3 FY26 actual revenue was Rs 259 Cr. Actual results may differ based on operating conditions.

Q: What is IFGL Refractories share price ahead of Q4 results?

IFGL Refractories trades at Rs 680 as of April 2026. 52-week high is Rs 1,050; 52-week low is Rs 598. 1-year return is -35%. Market cap is Rs 1,200 Cr.

Q: Will IFGL Refractories declare a dividend in Q4 2026?

IFGL Refractories is expected to declare Rs 3 as final dividend for FY26, subject to board approval on May 12, 2026 and subsequent AGM shareholder approval.

Q: Which analysts have a Buy rating on IFGL Refractories?

Motilal Oswal has a BUY rating and YES Securities has an ADD rating on IFGL Refractories based on publicly available research. Check the Univest Screener for the latest analyst ratings.

Q: What were IFGL Refractories Q3 FY26 results?

IFGL Refractories reported Q3 FY26 revenue of Rs 259 Cr and PAT of Rs 20 Cr. The Q4 FY26 results on May 12, 2026 provide the full-year FY26 comparison and first FY27 guidance.

Q: When do TCS and Infosys announce Q4 results 2026?

TCS declared Q4 FY26 results on April 9, 2026. HCL Technologies declared on April 22. HDFC Bank declared on April 19. Infosys Q4 FY26 results are scheduled for April 23, 2026.

Q: Is IFGL Refractories a good investment ahead of Q4 results?

This article does not constitute investment advice. IFGL Refractories trades at Rs 680 — down -35% from its peak. Analyst consensus Q4 revenue estimate is Rs 285 Cr and PAT estimate is Rs 22 Cr. Review the five factors and five risks above. Consult a SEBI-registered financial advisor before investing.

Recent Article

Chembond Chemicals Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Chambal Fertilizers & Chemicals Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Chaman Lal Setia Exports Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Chalet Hotels Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Cerebra Integrated Technologies Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook